Palvella Therapeutics, Inc. · NASDAQ:PVLA

BVF PARTNERS L P/IL's stake in Palvella Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

BVF PARTNERS L P/IL's stake in Palvella Therapeutics, Inc. fell to 4.70%, 672,789 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
4.70%
Shares
672,789
Intent
Passive
What changed
Fell below 5%
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P2.50%352,699
BVF I GP LLC2.50%352,699
BIOTECHNOLOGY VALUE FUND II LP1.90%265,660
BVF II GP LLC1.90%265,660
Biotechnology Value Trading Fund OS LP0.30%44,510
BVF Partners OS Ltd.0.30%44,510
BVF GP HOLDINGS LLC4.30%618,359
BVF PARTNERS L P/IL4.70%672,789
BVF INC/IL4.70%672,789
LAMPERT MARK N4.70%672,789

Source

View original at SEC

Related